GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (FRA:PGO) » Definitions » Future Policy Benefits

Prostatype Genomics AB (FRA:PGO) Future Policy Benefits


View and export this data going back to 2021. Start your Free Trial

What is Prostatype Genomics AB Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Prostatype Genomics AB (FRA:PGO) Business Description

Traded in Other Exchanges
Address
Gustaf III:s Boulevard 34, Solna, SWE, 169 73
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.